Prophylactic administration of recombinant human thrombopoietin attenuates XELOX or SOX regimen-induced thrombocytopaenia

Affiliations

quanfu li: Department of Medical Oncology, Ordos Central Hospital, China
gaowa jin: Department of Medical Oncology, Ordos Central Hospital, China
caihong jiang: Department of Medical Oncology, Ordos Central Hospital, China
zewei zhang: Department of Radiation Oncology, Sun Yat-sen University Cancer Centre; State Key Laboratory of Oncology in South China; Collaborative Innovation Centre for Cancer Medicine, China
jixiang hou: Department of Medical Oncology, Ordos Central Hospital, China
juan zhao: Department of Medical Oncology, Ordos Central Hospital, China
feng chen: Department of Medical Oncology, Ordos Central Hospital, China
zhenhao li: School of Public Health and Management, Wenzhou Medical University, Wenzhou, Zhejiang, China

Abstract

No abstracts available.